Several years ago, my linguistic research team and I began developing a computational tool we call "Read-y Grammarian." Our ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...

Inflation is hitting New Yorkers where it really hurts — in their morning cup of Joe. Coffee cart prices are creeping up as vendors scramble to keep up with ever-increasing supply costs – leaving ...

Incidents are common, and the remediation window is the risk: 23% reported a container security incident, and delays between disclosure and patching can leave known exposures in production. Java ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Digital sovereignty is about maintaining ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Square works well for smaller operations, but scaling businesses often need pricing flexibility, deeper industry tools, or more control over payments. These alternatives highlight where other ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...